These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

418 related items for PubMed ID: 28495456

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Role of Runx2 in crosstalk between Mek/Erk and PI3K/Akt signaling in MCF-10A cells.
    Tandon M, Chen Z, Pratap J.
    J Cell Biochem; 2014 Dec; 115(12):2208-17. PubMed ID: 25147082
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ, Fabris V, Doria ML, Lindberg K, Gustafsson JÅ, Amado F, Lanari C, Helguero LA.
    Oncogene; 2013 May 09; 32(19):2390-402. PubMed ID: 22751110
    [Abstract] [Full Text] [Related]

  • 26. Janus kinase 2 is required for the initiation but not maintenance of prolactin-induced mammary cancer.
    Sakamoto K, Triplett AA, Schuler LA, Wagner KU.
    Oncogene; 2010 Sep 30; 29(39):5359-69. PubMed ID: 20639901
    [Abstract] [Full Text] [Related]

  • 27. An integrated genomic approach identifies that the PI3K/AKT/FOXO pathway is involved in breast cancer tumor initiation.
    Smit L, Berns K, Spence K, Ryder WD, Zeps N, Madiredjo M, Beijersbergen R, Bernards R, Clarke RB.
    Oncotarget; 2016 Jan 19; 7(3):2596-610. PubMed ID: 26595803
    [Abstract] [Full Text] [Related]

  • 28. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways.
    Neilson LM, Zhu J, Xie J, Malabarba MG, Sakamoto K, Wagner KU, Kirken RA, Rui H.
    Mol Endocrinol; 2007 Sep 19; 21(9):2218-32. PubMed ID: 17550976
    [Abstract] [Full Text] [Related]

  • 29. JAK kinases overexpression promotes in vitro cell transformation.
    Knoops L, Hornakova T, Royer Y, Constantinescu SN, Renauld JC.
    Oncogene; 2008 Mar 06; 27(11):1511-9. PubMed ID: 17873904
    [Abstract] [Full Text] [Related]

  • 30. Cyclophilin A Function in Mammary Epithelium Impacts Jak2/Stat5 Signaling, Morphogenesis, Differentiation, and Tumorigenesis in the Mammary Gland.
    Volker SE, Hedrick SE, Feeney YB, Clevenger CV.
    Cancer Res; 2018 Jul 15; 78(14):3877-3887. PubMed ID: 29959151
    [Abstract] [Full Text] [Related]

  • 31. Controlled synchronization of prolactin/STAT5 and AKT1/mTOR in bovine mammary epithelial cells.
    Wang B, Shi L, Men J, Li Q, Hou X, Wang C, Zhao F.
    In Vitro Cell Dev Biol Anim; 2020 Mar 15; 56(3):243-252. PubMed ID: 32078727
    [Abstract] [Full Text] [Related]

  • 32. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice.
    Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H.
    Mol Cell Biol; 2004 Jun 15; 24(12):5510-20. PubMed ID: 15169911
    [Abstract] [Full Text] [Related]

  • 33. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
    Wu AM, Dalvi P, Lu X, Yang M, Riddick DS, Matthews J, Clevenger CV, Ross DD, Harper PA, Ito S.
    Mol Pharmacol; 2013 Feb 15; 83(2):377-88. PubMed ID: 23150485
    [Abstract] [Full Text] [Related]

  • 34. TDAG51 is an ERK signaling target that opposes ERK-mediated HME16C mammary epithelial cell transformation.
    Oberst MD, Beberman SJ, Zhao L, Yin JJ, Ward Y, Kelly K.
    BMC Cancer; 2008 Jul 02; 8():189. PubMed ID: 18597688
    [Abstract] [Full Text] [Related]

  • 35. Activated STAT5 proteins induce activation of the PI 3-kinase/Akt and Ras/MAPK pathways via the Gab2 scaffolding adapter.
    Nyga R, Pecquet C, Harir N, Gu H, Dhennin-Duthille I, Régnier A, Gouilleux-Gruart V, Lassoued K, Gouilleux F.
    Biochem J; 2005 Aug 15; 390(Pt 1):359-66. PubMed ID: 15833084
    [Abstract] [Full Text] [Related]

  • 36. Transcriptional activation of signal transducer and activator of transcription (STAT) 3 and STAT5B partially mediate homeobox A1-stimulated oncogenic transformation of the immortalized human mammary epithelial cell.
    Mohankumar KM, Perry JK, Kannan N, Kohno K, Gluckman PD, Emerald BS, Lobie PE.
    Endocrinology; 2008 May 15; 149(5):2219-29. PubMed ID: 18276758
    [Abstract] [Full Text] [Related]

  • 37. Co-overexpression of Janus kinase 2 and signal transducer and activator of transcription 5a promotes differentiation of mammary cancer cells through reversal of epithelial-mesenchymal transition.
    Sultan AS, Brim H, Sherif ZA.
    Cancer Sci; 2008 Feb 15; 99(2):272-9. PubMed ID: 18271926
    [Abstract] [Full Text] [Related]

  • 38. Oncogenic Kit controls neoplastic mast cell growth through a Stat5/PI3-kinase signaling cascade.
    Harir N, Boudot C, Friedbichler K, Sonneck K, Kondo R, Martin-Lannerée S, Kenner L, Kerenyi M, Yahiaoui S, Gouilleux-Gruart V, Gondry J, Bénit L, Dusanter-Fourt I, Lassoued K, Valent P, Moriggl R, Gouilleux F.
    Blood; 2008 Sep 15; 112(6):2463-73. PubMed ID: 18579792
    [Abstract] [Full Text] [Related]

  • 39. Key signalling nodes in mammary gland development and cancer. Signalling downstream of PI3 kinase in mammary epithelium: a play in 3 Akts.
    Wickenden JA, Watson CJ.
    Breast Cancer Res; 2010 Sep 15; 12(2):202. PubMed ID: 20398329
    [Abstract] [Full Text] [Related]

  • 40. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
    García-Martínez JM, Calcabrini A, González L, Martín-Forero E, Agulló-Ortuño MT, Simon V, Watkin H, Anderson SM, Roche S, Martín-Pérez J.
    Cell Signal; 2010 Mar 15; 22(3):415-26. PubMed ID: 19892015
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.